The Journal of Organic Chemistry
Article
Scheme 3. A Plausible Reaction Mechanism
CDCl3) δ 7.70 (s, 1H), 7.34−7.32 (m, 3H), 7.22−7.14 (m, 3H),
6.97−6.94 (m, 2H), 5.40 (s, 2H) ppm; 13C NMR (100 MHz, CDCl3)
δ 136.5, 134.9, 133.9, 131.7, 128.9, 128.6, 128.3, 128.2, 128.1, 125.9,
52.9 ppm; HRMS (ESI-ion trap) m/z [M + H]+ calcd for
C15H12Cl2N3, 304.0408; found 304.0387.
accelerated the reaction by increasing the electrophilicity of the
nitroolefin through coordination. The second step is the
elimination of HNO2 of the intermediate 4 leading to 1,5-
disubstituted 1,2,3-triazoles 2.
1-Benzyl-5-(4-nitrophenyl)-1H-1,2,3-triazole5g (2f). Yellow solid
CONCLUSIONS
1
■
(123 mg, 88%); mp 96−99 °C; H NMR (400 MHz, CDCl3) δ 8.25
We have disclosed the first rare earth metal-catalyzed [3 + 2]
cycloaddition of organic azides with nitroolefins to yield 1,5-
disubstituted 1,2,3-triazoles with good to excellent yields. Easily
available starting materials, experimentally convenient catalytic
process, as well as less expensive catalyst were the advantages of
the present procedure. Furthermore, this catalytic process did
not require dried glassware and an inert atmposphere. Further
study to explore the rare earth metal-catalyzed reactions of
azides with olefins to construct the biologically active molecules
is ongoing in our laboratory.
(d, J = 8.7 Hz, 2H), 7.83 (s, 1H), 7.43 (d, J = 8.8 Hz, 2H), 7.31−7.28
(m, 3H), 7.10−7.01 (m, 2H), 5.60 (s, 2H) ppm; 13C NMR (100 MHz,
CDCl3) δ 148.3, 134.8, 134.1, 131.1, 129.7, 129.1, 128.6, 127.6, 126.9,
124.1, 52.4 ppm; HRMS (ESI-ion trap) m/z [M + H]+ calcd for
C15H13N4O2, 281.1039; found 281.1018.
1-Benzyl-5-(2-nitrophenyl)-1H-1,2,3-triazole10 (2g). Yellow solid
1
(126 mg, 90%); mp 149−151 °C; H NMR (400 MHz, CDCl3) δ
8.15−8.07 (m, 1H), 7.68−7.61 (m, 2H), 7.56−7.52 (m, 1H), 7.24−
7.16 (m, 5H), 7.02 (dd, J = 7.6, 1.3 Hz, 1H), 5.41 (s, 2H) ppm; 13C
NMR (100 MHz, CDCl3) δ 148.5, 134.2, 133.9, 133.3, 133.2, 133.1,
131.1, 128.7, 128.4, 127.8, 124.9, 122.1, 52.8 ppm; HRMS (APCI-ion
trap) m/z [M + H]+ calcd for C15H13N4O2, 281.1039; found 281.1019.
4-(1-Benzyl-1H-1,2,3-triazol-5-yl)benzonitrile (2h). Yellow solid
EXPERIMENTAL SECTTION
■
1
(114 mg, 88%); mp 84−86 °C; H NMR (400 MHz, CDCl3) δ 7.80
General Experimental Procedure for Synthesis of 1,5-
Disubstituted 1,2,3-Triazoles 2. A mixture of nitroolefin (1.0
equiv, 0.5 mmol), azide (1.2 equiv, 0.6 mmol), Ce(OTf)3 (0.05 equiv,
0.025 mmol), and 2 mL of toluene was refluxed at 100 °C for 8 or 16
h. The progress of the reaction was monitored by thin-layer
chromatography. The mixture was then cooled and evaporated
under reduced pressure. The target product 2 was purified by column
chromatography on silica gel using a mixture of ethyl acetate and
petroleum ether.
(s, 1H), 7.73−7.65 (m, 2H), 7.39−7.34 (m, 2H), 7.32−7.25 (m, 3H),
7.08−6.98 (m, 2H), 5.57 (s, 2H) ppm; 13C NMR (100 MHz, CDCl3)
δ 136.4, 134.9, 133.909, 132.7, 131.5, 129.4, 129.1, 128.5, 126.9, 117.9,
113.4, 52.3 ppm; HRMS (ESI-ion trap) m/z [M + H]+ calcd for
C16H13N4, 261.1140; found 261.1132.
1-Benzyl-5-(4-methylphenyl)-1H-1,2,3-triazole6d (2i). Colorless oil
1
(100 mg, 80%); H NMR (400 MHz, CDCl3) δ 7.71 (s, 1H), 7.29−
7.26 (m, 3H), 7.22 (d, J = 8.0 Hz, 2H), 7.14 (d, J = 8.1 Hz, 2H), 7.09−
7.07(m, 2H), 5.53 (s, 2H), 2.39 (s, 3H) ppm; 13C NMR (100 MHz,
CDCl3) δ 139.6, 138.2, 135.7, 133.1, 129.6, 128.8, 128.8, 128.1, 127.1,
123.9, 51.7, 21.3 ppm; HRMS (APCI-ion trap) m/z [M + H]+ calcd
for C16H16N3, 250.1344; found 250.1328.
1-Benzyl-5-phenyl-1H-1,2,3-triazole5g (2a). White solid (100 mg,
1
85%); mp 72−74 °C; H NMR (400 MHz, CDCl3) δ 7.74 (s, 1H),
7.47−7.34 (m, 3H), 7.34−7.27 (m, 5H), 7.11−7.03 (m, 2H), 5.55 (s,
2H) ppm; 13C NMR (100 MHz, CDCl3) δ 138.2, 135.5, 133.3, 129.5,
128.9, 128.9, 128.8, 128.1, 127.1, 126.9, 51.8 ppm; HRMS (ESI-ion
trap) m/z [M + H]+ calcd for C15H14N3, 236.1188; found, 236.1185.
1-Benzyl-5-(2-chlorophenyl)-1H-1,2,3-triazole (2b). White solid
1-Benzyl-5-(4-methoxyphenyl)-1H-1,2,3-triazole6d (2j). Pale yel-
1
low oil (99 mg, 75%); H NMR (400 MHz, CDCl3) δ 7.70 (s, 1H),
7.30−7.27 (m, 3H), 7.17−7.14 (m, 2H), 7.09−7.07 (m, 2H), 6.94−
6.90 (m, 2H), 5.53 (s, 2H), 3.84 (s, 3H) ppm; 13C NMR (100 MHz,
CDCl3) δ 160.5, 137.9, 135.7, 133.1, 130.3, 128.8, 128.1, 127.1, 118.9,
114.4, 55.4, 51.7 ppm; HRMS (APCI-ion trap) m/z [M + H]+ calcd
for C16H16N3O, 266.1293; found 266.1279.
1
(120 mg, 89%); mp 58−60 °C; H NMR (400 MHz, CDCl3) δ 7.71
(s, 1H), 7.49 (dd, J = 8.1, 1.0 Hz, 1H), 7.41−7.38 (m, 1H), 7.28−7.16
(m, 4H), 7.01 (dd, J = 7.6, 1.6 Hz, 1H), 6.95 (dd, J = 7.5, 1.7 Hz, 2H),
5.44 (s, 2H) ppm; 13C NMR (100 MHz, CDCl3) δ 134.8, 134.8, 134.4,
134.3, 132.0, 131.2, 129.9, 128.6, 128.2, 127.7, 126.9, 126.4, 52.5 ppm;
HRMS (ESI-ion trap) m/z [M + H]+ calcd for C15H13ClN3, 270.0798;
found 270.0781.
5-(1,3-Benzodioxol-5-yl)-1-benzyl-1H-1,2,3-triazole (2k). Yellow
1
oil (106 mg, 76%); H NMR (400 MHz, CDCl3) δ 7.67 (s, 1H),
7.34−7.25 (m, 3H), 7.12−7.05 (m, 2H), 6.83 (d, J = 8.0 Hz, 1H),
6.75−6.66 (m, 2H), 6.01 (s, 2H), 5.53 (s, 2H) ppm; 13C NMR (100
MHz, CDCl3) δ 148.7, 148.1, 137.9, 135.5, 133.2, 128.9, 128.2, 127.1,
123.0, 120.2, 109.1, 108.8, 101.6, 51.7 ppm; HRMS (ESI-ion trap) m/z
[M + H]+ calcd for C16H14N3O2, 280.1086; found 280.1071.
1-Benzyl-5-(3-bromophenyl)-1H-1,2,3-triazole (2c). Yellow solid
1
(140 mg, 90%); mp 68−70 °C; H NMR (400 MHz, CDCl3) δ 7.70
(s, 1H), 7.67 (dd, J = 7.8, 1.4 Hz, 1H), 7.35−7.24 (m, 2H), 7.24−7.15
(m, 3H), 7.02−6.91 (m, 3H), 5.43 (s, 2H) ppm; 13C NMR (100 MHz,
CDCl3) δ 136.4, 134.7, 134.3, 133.1, 132.1, 131.3, 128.6, 128.4, 128.2,
127.8, 127.4, 124.3, 52.5 ppm; HRMS (ESI-ion trap) m/z [M + H]+
calcd for C15H13N3Br, 314.0293, 316.0272; found 314.0275, 316.0255.
1-Benzyl-5-(2-chloro-6-fluorophenyl)-1H-1,2,3-triazole (2d).
1-Benzyl-5-[3-(benzyloxy)-4-methoxyphenyl]-1H-1,2,3-triazole
1
(2l). Yellow oil (131 mg, 71%); H NMR (400 MHz, CDCl3) δ 7.69
(s, 1H), 7.44−7.26 (m, 8H), 7.11−7.04 (m, 2H), 6.90 (d, J = 8.3 Hz,
1H), 6.76 (dd, J = 8.2, 2.0 Hz, 1H), 6.62 (d, J = 1.9 Hz, 1H), 5.52 (s,
2H), 5.18 (s, 2H), 3.65 (s, 3H) ppm; 13C NMR (100 MHz, CDCl3) δ
149.7, 149.1, 138.1, 136.5, 135.9, 133.1, 128.9, 128.7, 128.1, 128.1,
127.3, 126.9, 121.6, 119.6, 113.8, 112.3, 70.9, 55.8, 51.7 ppm; HRMS
(ESI-ion trap) m/z [M + H]+ calcd for C23H22N3O2, 372.1712; found
372.1688.
1
White solid (126 mg, 88%); mp 62−65 °C; H NMR (400 MHz,
CDCl3) δ 7.72 (s, 1H), 7.37−7.31 (m, 1H), 7.22 (d, J = 8.2 Hz, 1H),
7.20−7.09 (m, 3H), 6.99 (m, 1H), 6.92−6.89 (m, 2H), 5.42 (s, 2H)
1
ppm; 13C NMR (100 MHz, CDCl3) δ 160.4 (d, JCF = 250.1 Hz),
4
3
135.6 (d, JCF = 3 Hz), 135.5, 134.1, 132.2 (d, JCF = 9.4 Hz), 128.6,
128.6, 128.3, 127.6, 125.6 (d, 4JCF = 3.6 Hz), 115.3 (d, 2JCF = 18.6 Hz),
114.3 (d, 2JCF = 21.7 Hz), 52.9 ppm; HRMS (ESI-ion trap) m/z [M +
H]+ calcd for C15H12ClFN3, 288.0704; found 288.0694.
4-(1-Benzyl-1H-1,2,3-triazol-5-yl)-N,N-dimethylamine (2m). Red
solid (97 mg, 70%); mp 132−134 °C (lit.11 132 °C); H NMR (400
1
MHz, CDCl3) δ 7.67 (s, 1H), 7.34−7.25 (m, 3H), 7.13−7.10 (m, 4H),
6.71−6.67 (m, 2H), 5.54 (s, 2H), 3.00 (s, 6H) ppm; 13C NMR (100
MHz, CDCl3) δ 150.9, 138.7, 136.0, 132.6, 129.7, 128.8, 127.9, 127.1,
1-Benzyl-5-(2,6-dichlorophenyl)-1H-1,2,3-triazole (2e). Yellow
solid (144 mg, 95%); mp 118−120 °C; 1H NMR (400 MHz,
E
dx.doi.org/10.1021/jo5004339 | J. Org. Chem. XXXX, XXX, XXX−XXX